(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202109 | 202009 | % Var | 202109 | 202009 | % Var | 202103 | 202003 | % Var | |
| Sales | 19.51 | 16.08 | 21.33 | 38.01 | 30.24 | 25.69 | 61.59 | 76.03 | -18.99 |
| Other Income | 0.29 | 0.58 | -50.00 | 0.70 | 0.90 | -22.22 | 1.91 | 1.35 | 41.48 |
| PBIDT | 2.06 | 1.42 | 45.07 | 3.87 | 2.78 | 39.21 | 5.22 | 4.38 | 19.18 |
| Interest | 0.19 | 0.14 | 35.71 | 0.39 | 0.37 | 5.41 | 0.87 | 0.67 | 29.85 |
| PBDT | 1.87 | 1.28 | 46.09 | 3.48 | 2.41 | 44.40 | 4.35 | 3.71 | 17.25 |
| Depreciation | 0.50 | 0.46 | 8.70 | 1.00 | 0.92 | 8.70 | 1.91 | 1.95 | -2.05 |
| PBT | 1.37 | 0.82 | 67.07 | 2.48 | 1.49 | 66.44 | 2.44 | 1.76 | 38.64 |
| TAX | 0.37 | 0.17 | 117.65 | 0.65 | 0.30 | 116.67 | 0.38 | 0.46 | -17.39 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.40 | -0.24 | 66.67 |
| PAT | 1.00 | 0.65 | 53.85 | 1.83 | 1.19 | 53.78 | 2.06 | 1.30 | 58.46 |
| Equity | 35.45 | 35.44 | 0.03 | 45.71 | 35.44 | 28.98 | 35.44 | 35.44 | 0.00 |
| PBIDTM(%) | 10.56 | 8.83 | 19.57 | 10.18 | 9.19 | 10.75 | 8.48 | 5.76 | 47.12 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1866.25 |
| Dr. Reddys Labs. | 1333.90 |
| Cipla | 1429.65 |
| Zydus Lifesciences | 1106.70 |
| Lupin | 2374.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: